What is Home Hemodialysis?
Home Hemodialysis (HHD) is the provision of hemodialysis in the home of a person whose kidneys are not functioning normally. One advantage of doing dialysis at home is that it can be done more frequently and slowly, reducing the washed-out feeling and other symptoms caused by rapid ultrafiltration, and it can often be done at night while the person is sleeping. People on home hemodialysis are prescribed dialysis by a nephrologist and rely on the support of a dialysis unit for backup treatments and case management. HHD improves patients' sense of well-being, the more they understand and control their own treatment, the better they will do on dialysis.
|Unit||Value (USD Million)|
|Key Companies Profiled||Becton, Dickinson and Company (United States), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGaA (Germany), Asahi Kasei Medical Co., Ltd. (Japan), Baxter International Inc. (United States), Braun Melsungen AG (Germany), MEDTRONIC PUBLIC LIMITED COMPANY (Ireland), Nipro Corporation (Japan), Toray Industries, Inc. (Japan) and Quanta Dialysis Technologies (United Kingdom)|
The study covers a detailed analysis segmented by key business segments i.e. by type (Hemodialysis, Peritoneal Dialysis, Device, Consumables and Others) , by application (Drug Store and On-line) and major geographies. Research Analyst at AMA predicts that United States & German Players will contribute to the maximum growth of Global Home Hemodialysis market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Home Hemodialysis market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Becton, Dickinson and Company (United States), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGaA (Germany), Asahi Kasei Medical Co., Ltd. (Japan), Baxter International Inc. (United States), Braun Melsungen AG (Germany), MEDTRONIC PUBLIC LIMITED COMPANY (Ireland), Nipro Corporation (Japan), Toray Industries, Inc. (Japan) and Quanta Dialysis Technologies (United Kingdom).
On 7th April 2022, Dialyze Direct, the nationís leading provider of home hemodialysis services in skilled nursing facilities (SNFs), is pleased to announce that it has completed its announced acquisition of Compass Home Dialysis, a regional dialysis provider in Pennsylvania with on-site dialysis services in nine SNFs, as well as an outpatient dialysis clinic.
Centers for Medicare & Medicaid Services (CMS) Survey and Certification Program certifies ESRD facilities for Medicare Program inclusion by validating that each facility's care and services meet specified safety and quality standards known as Conditions for Coverage. The CMS Dialysis Page provides ESRD surveyors and dialysis providers with basic information about surveying and certifying dialysis facilities. It contains links to applicable laws and regulations as well as resources to help support and assess compliance with federal regulations.
The Home Hemodialysis market is highly diversified and competitive with a large number of players. Tier-I firms, mid-tier firms, and start-up firms are among the market participants. In this highly competitive market, businesses are attempting to gain market visibility. Furthermore, due to the high capital requirements for manufacturing and marketing products as well as the time-consuming regulatory approval process, many companies (particularly start-ups and small businesses) struggle to survive and keep up with the industry's growth. This can be a significant barrier for a company to develop a long-term innovation capability across all market segments.
Demand for Home Hemodialysis Is Increasing
- Adverse Effects of Poor Hygiene and Repeated Hemodialysis
- Dialysis-Related Risks and Complications
- Complications and Risks Associated With Dialysis
Unmet Demand Is Expected To Drive the Global Hemodialysis Chairs Market during the Forecast Period and Increased Awareness of Various Types of Infections in Developing Countries
Key highlights of the Global Home Hemodialysis market Study:
CAGR of the market during the forecast period 2021-2027
In-depth information on growth factors that will accelerate the Home Hemodialysis market in next few years.
Detailed Insights on futuristic trends and changing consumer behaviour
Forecast of the Global Home Hemodialysis market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Home Hemodialysis Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Home Hemodialysis market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Home Hemodialysis market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Venture and Capitalist, Home Hemodialysis Distributor & Suppliers, Corporate Entities, Government Research Organizations, Private Research Organization, Government Bodies, End-Users and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.